UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 60

Sortiert nach

Tumor-specific IL-9–producing CD8⁺ Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers

Proceedings of the National Academy of Sciences - PNAS, 2014-02, Vol.111 (6), p.2265-2270

2014

Volltextzugriff (PDF)

NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor Immunotherapy

Clinical cancer research, 2022-04, Vol.28 (7), p.1460-1473

2022

Volltextzugriff (PDF)

Replication and Spread of Oncolytic Herpes Simplex Virus in Solid Tumors

Viruses, 2022-01, Vol.14 (1), p.118

2022

Volltextzugriff (PDF)

1098 Oncolytic HSV blocking tumor-intrinsic PKR sensitizes glioblastoma to immunotherapy

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1209-A1209

2023

Volltextzugriff (PDF)

PTEN expression by an oncolytic herpesvirus directs T-cell mediated tumor clearance

Nature communications, 2018-11, Vol.9 (1), p.5006-16, Article 5006

2018

Volltextzugriff (PDF)

Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity

Clinical cancer research, 2021-01, Vol.27 (2), p.542-553

2021

Volltextzugriff (PDF)

Oncolytic HSV therapy increases trametinib access to brain tumors and sensitizes them in vivo

Neuro-oncology (Charlottesville, Va.), 2019-09, Vol.21 (9), p.1131-1140

2019

Volltextzugriff (PDF)

HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiforme

BMC cancer, 2022-04, Vol.22 (1), p.400-13, Article 400

2022

Volltextzugriff (PDF)

oHSV-P10 reduces glioma stem cell enrichment after oncolytic HSV therapy

Molecular therapy. Oncolytics, 2023-06, Vol.29, p.30-41

2023

Volltextzugriff (PDF)

PKR induces TGF-β and limits oncolytic immune therapy

Journal for immunotherapy of cancer, 2023-02, Vol.11 (2), p.e006164

2023

Volltextzugriff (PDF)

Suppression of HMGB1 Released in the Glioblastoma Tumor Microenvironment Reduces Tumoral Edema

Molecular therapy. Oncolytics, 2019-03, Vol.12, p.93-102

2019

Volltextzugriff (PDF)

esRAGE-expressing oHSV enhances anti-tumor efficacy by inhibition of endothelial cell activation

Molecular therapy. Oncolytics, 2023-03, Vol.28, p.171-181

2023

Volltextzugriff (PDF)

Human Suppressor of Cytokine Signaling 1 Controls Immunostimulatory Activity of Monocyte-Derived Dendritic Cells

Cancer research (Chicago, Ill.), 2009-10, Vol.69 (20), p.8076-8084

2009

Volltextzugriff (PDF)

Bone marrow stromal cells derived MCP-1 reverses the inhibitory effects of multiple myeloma cells on osteoclastogenesis by upregulating the RANK expression

PloS one, 2013-12, Vol.8 (12), p.e82453-e82453

2013

Volltextzugriff (PDF)

Anti‐β2M monoclonal antibodies kill myeloma cells via cell‐ and complement‐mediated cytotoxicity

International journal of cancer, 2014-09, Vol.135 (5), p.1132-1141

2014

Volltextzugriff (PDF)

A20 controls macrophage to elicit potent cytotoxic CD4(+) T cell response

PloS one, 2012-11, Vol.7 (11), p.e48930

2012

Volltextzugriff (PDF)

Embryonic Stem Cells and Mammary Luminal Progenitors Directly Sense and Respond to Microbial Products

Stem cells (Dayton, Ohio), 2009-07, Vol.27 (7), p.1604-1615

2009

Volltextzugriff (PDF)

A super TLR agonist to improve efficacy of dendritic cell vaccine in induction of anti-HCV immunity

PloS one, 2012-11, Vol.7 (11), p.e48614-e48614

2012

Volltextzugriff (PDF)

TMIC-04. TARGETING AN ECM PROTEIN INVOLVED IN BREAST CANCER BRAIN METASTASES WITH AN ONCOLYTIC HSV-1

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii271-vii271

2022

Volltextzugriff (PDF)

EXTH-51. HSV-PTENΑ TREATMENT TARGETS GLIOMA STEM CELLS TO REDUCE STEMNESS AND SENSITIZES GLIOBLASTOMA TO IRRADIATION

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii220-vii220

2022

Volltextzugriff (PDF)

Th9 cells promote antitumor immune responses in vivo

The Journal of clinical investigation, 2012-11, Vol.122 (11), p.4160-4171

2012

Volltextzugriff (PDF)

TMIC-39. TARGETING EXTRACELLULAR MATRIX HYALURONIC ACID-CD44 SIGNALING REDUCES TUMOR STEMNESS AND SENSITIZES TUMOR TO VIROTHERAPY AND ENHANCES THERAPEUTIC POTENTIAL FOR CANCER TREATMENT

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii280-vii280

2022

Volltextzugriff (PDF)

620. Cancer Associated Fibroblasts-Targeted Oncolytic Virus Results in Enhanced Antitumor Activity in Mouse Model

Molecular therapy, 2015-05, Vol.23, p.S246-S246

2015

Volltextzugriff (PDF)

EXTH-42. DUAL ROLES OF PKR ORCHESTRATE ONCOLYTIC HSV SENSITIVITY AND ANTIGEN-SPECIFIC T CELL EXPANSION

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii218-vii218

2022

Volltextzugriff (PDF)

EXTH-77. TARGETING CD73 IN GBM SENSITIZES TUMORS TO ONCOLYTIC VIRUS THERAPY

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii227-vii227

2022

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(59)
Buchkapitel
(1)

Sprache

Englisch
(60)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tumor-specific IL-9–producing CD8⁺ Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers

NOTCH-Induced MDSC Recruitment after oHSV Virotherapy in CNS Cancer Models Modulates Antitumor Immunotherapy

Replication and Spread of Oncolytic Herpes Simplex Virus in Solid Tumors

1098 Oncolytic HSV blocking tumor-intrinsic PKR sensitizes glioblastoma to immunotherapy

PTEN expression by an oncolytic herpesvirus directs T-cell mediated tumor clearance

Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity

Oncolytic HSV therapy increases trametinib access to brain tumors and sensitizes them in vivo

HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiforme

oHSV-P10 reduces glioma stem cell enrichment after oncolytic HSV therapy

PKR induces TGF-β and limits oncolytic immune therapy

Suppression of HMGB1 Released in the Glioblastoma Tumor Microenvironment Reduces Tumoral Edema

esRAGE-expressing oHSV enhances anti-tumor efficacy by inhibition of endothelial cell activation

Human Suppressor of Cytokine Signaling 1 Controls Immunostimulatory Activity of Monocyte-Derived Dendritic Cells

Bone marrow stromal cells derived MCP-1 reverses the inhibitory effects of multiple myeloma cells on osteoclastogenesis by upregulating the RANK expression

Anti‐β2M monoclonal antibodies kill myeloma cells via cell‐ and complement‐mediated cytotoxicity

A20 controls macrophage to elicit potent cytotoxic CD4(+) T cell response

Embryonic Stem Cells and Mammary Luminal Progenitors Directly Sense and Respond to Microbial Products

A super TLR agonist to improve efficacy of dendritic cell vaccine in induction of anti-HCV immunity

TMIC-04. TARGETING AN ECM PROTEIN INVOLVED IN BREAST CANCER BRAIN METASTASES WITH AN ONCOLYTIC HSV-1

EXTH-51. HSV-PTENΑ TREATMENT TARGETS GLIOMA STEM CELLS TO REDUCE STEMNESS AND SENSITIZES GLIOBLASTOMA TO IRRADIATION

Th9 cells promote antitumor immune responses in vivo

TMIC-39. TARGETING EXTRACELLULAR MATRIX HYALURONIC ACID-CD44 SIGNALING REDUCES TUMOR STEMNESS AND SENSITIZES TUMOR TO VIROTHERAPY AND ENHANCES THERAPEUTIC POTENTIAL FOR CANCER TREATMENT

620. Cancer Associated Fibroblasts-Targeted Oncolytic Virus Results in Enhanced Antitumor Activity in Mouse Model

EXTH-42. DUAL ROLES OF PKR ORCHESTRATE ONCOLYTIC HSV SENSITIVITY AND ANTIGEN-SPECIFIC T CELL EXPANSION

EXTH-77. TARGETING CD73 IN GBM SENSITIZES TUMORS TO ONCOLYTIC VIRUS THERAPY

Suchergebnisse filtern